Anixa Biosciences receives Mexican patent for breast cancer vaccine
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Anixa Biosciences Announces Issuance of Mexican Patent Covering Breast Cancer Vaccine Technology
April 29, 2026 9:10 AM EDTExpands global intellectual property coverage in markets with greater late-stage breast cancer
diagnoses and higher triple-negative breast cancer incidence rates
New patent will provide IP protection of Breast Cancer Vaccine in Mexico into 2040
SAN JOSE, Calif., April 29, 2026 /PRNewswire/ --Â Anixa Biosciences,... More
